- Details
- Description
Strength:
0.75 mg
Composition:
Atrasentan
Treatment:
IgA nephropathy (IgAN) / proteinuric chronic kidney disease
Form:
Tablets
Brand:
LuciAtras
Quantity Unit:
Tablets
Manufacturer:
Lucius Pharmaceuticals (Lao) Co., Ltd.
LuciAtras (Atrasentan) is a pharmaceutical product containing atrasentan, a selective endothelin A (ETA) receptor antagonist. It acts on the endothelin system, which plays an important role in regulating vascular tone and kidney function.
Atrasentan has been studied for use in certain kidney-related conditions, including chronic kidney disease in patients with type 2 diabetes and albuminuria. The medicine should be used under the supervision of a qualified healthcare professional, taking into account the patient’s medical condition, indications, contraindications, and individual risk factors.
